As of 4:00pm ET
| -0.30 / -1.00%|
The 13 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 40.00, with a high estimate of 56.00 and a low estimate of 33.00. The median estimate represents a +34.91% increase from the last price of 29.65.
The current consensus among 13 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.